IMPL - Impel Pharmaceuticals Inc
Close
0.2411
-0.173 -71.796%
Share volume: 858,521
Last Updated: Fri 15 Dec 2023 10:00:01 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.41
-0.17
-41.79%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-27 | 2023-05-12 | 2023-08-18 | 2023-11-14 | |
| Total revenue | 1.759 M | 2.803 M | 3.082 M | 5.008 M | 4.372 M | 6.584 M | 5.023 M | |
| Cost of revenue | 1.033 M | 1.737 M | 1.508 M | 2.217 M | 2.285 M | 3.220 M | 2.230 M | |
| Gross profit | 726.000 K | 1.066 M | 1.574 M | 2.791 M | 2.087 M | 3.364 M | 2.793 M | |
| 46.83% | 47.65% | 77.32% | -25.22% | 61.19% | -16.97% | |||
| Operating expenses | 23.449 M | 22.046 M | 22.814 M | 21.032 M | 25.040 M | 19.468 M | 15.604 M | |
| Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Research and development | 23.449 M | 22.046 M | 22.814 M | 21.032 M | 25.040 M | 19.468 M | 15.604 M | |
| Total expenses | 24.482 M | 23.783 M | 24.322 M | 23.249 M | 27.325 M | 22.688 M | 17.834 M | |
| -2.86% | 2.27% | -4.41% | 17.53% | -16.97% | -21.39% | |||
| Operating income | -22.723 M | -20.980 M | -21.240 M | -18.241 M | -22.953 M | -16.104 M | -12.811 M | |
| Ebit | -22.723 M | -20.980 M | -21.240 M | -18.241 M | -22.953 M | -16.104 M | -12.811 M | |
| Pretax income | -26.970 M | -25.204 M | -31.097 M | -23.041 M | -30.067 M | -7.357 M | -13.814 M | |
| -6.55% | 23.38% | -25.91% | 30.49% | -75.53% | 87.77% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -26.970 M | -25.204 M | -31.097 M | -23.041 M | -30.067 M | -7.357 M | -13.814 M | |
| 6.55% | -23.38% | 25.91% | -30.49% | 75.53% | -87.77% | |||
| Net income | -26.970 M | -25.204 M | -31.097 M | -23.041 M | -30.067 M | -7.357 M | -13.814 M | |
| 6.55% | -23.38% | 25.91% | -30.49% | 75.53% | -87.77% |